[Gold-induced pulmonary disease: clinical features, outcomes, and differentiation from rheumatoid lung disease].
Schnabel
A
A
Poliklinik für Rheumatologie, Medizinische Universität Lübeck.
D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D003937:Diagnosis, Differential; D006801:Humans; D050607:Organogold Compounds; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000175:diagnosis; D014057:Tomography, X-Ray Computed
D018501:Antirheumatic Agents; D050607:Organogold Compounds